Nav: Home

Atrial fibrillation patients may safely discontinue blood thinners after successful ablation

March 17, 2017

PHILADELPHIA -- Atrial fibrillation (AF) is a quivering or irregular heartbeat that can lead to blood clots, stroke, heart failure and other cardiovascular complications, and it is estimated to afflict nearly three million Americans. For patients with persistent AF or those who are at high risk for recurring AF, catheter ablation -- a minimally invasive procedure in which the areas of the heart causing the irregularity are cauterized -- is recommended, followed most often by continued use of blood thinners, regardless of whether the ablation procedure was effective. However, little is known about the actual need for these drugs following a successful ablation. In new study presented today at the American College of Cardiology 66th Annual Scientific Session, researchers from the Perelman School of Medicine at the University of Pennsylvania have found that patients with persistent AF, who are successfully treated with ablation many, in fact, no longer need blood thinners.

"There are two schools of thought when it comes to anticoagulant therapy following catheter ablation for the treatment of AF," said the study's presenter Jackson J. Liang, DO, a third-year cardiovascular disease fellow in the Perelman School of Medicine at the University of Pennsylvania. "Those who think all patients with AF should be prescribed blood thinners based on stroke risk scores even after their AF has been 'cured' by successful ablation, and those who believe that if there is no evidence of AF recurrence following ablation, then anticoagulants may be unnecessary."

In this retrospective study, researchers evaluated 400 participants with persistent and longstanding persistent - uninterrupted AF lasting more than1 year - who underwent one or more ablations, to determine the patterns of anticoagulation use after ablation based on AF recurrences, as well as likelihood of developing stroke or major bleeds after the procedure.

Participants were instructed to check their pulse two times per day, participate in routine outpatient telemetry monitoring to evaluate for asymptomatic AF, and to have symptom-driven electrocardiograms (EKGs), when needed. Following the roughly three-year follow-up period, 172 patients were free of AF recurrence, 161 were transformed to paroxysmal (sudden) AF, and 67 remained in persistent AF. Most interestingly, 207 had discontinued blood thinner use at some point in the three years, and 174 remained off blood thinners at their last follow-up. Participants who no longer experienced AF recurrence after their last ablation were more likely to have been removed from blood thinners as compared to those with whose AF was transformed to paroxysmal AF or those who remained in persistent AF.

"This data shows that in certain patients with nonparoxysmal AF who no longer have recurring AF following catheter ablation as confirmed by routine monitoring and daily pulse checks, anticoagulation may be safely discontinued to minimize the risk for major bleeding," said the study's senior author, David Callans, MD, the associate director of Electrophysiology for the University of Pennsylvania Health System.

Patients with recurring AF or those who are high risk for persistent AF are subsequently at higher risk for cerebrovascular such as stroke or transient ischemic attack (mini stroke). At the same time, those who stay on blood thinners long term, even after successful ablation, have an increased risk of intracranial hemorrhage, gastrointestinal bleeding, and internal bleeding and bruising after falls. In general, patients on blood thinners often need more regular doctors' visits, in some cases they may need to wear a medical bracelet to denote their risk of bleeding in case of emergency, fall or small injury, and they should be more cautious of the foods they eat other medications they take, including other prescription drugs, supplements, and anti-inflammatory medications.

The data collected in this study points to the need for larger, randomized trials examining the relationship between discontinuation of anticoagulation and strokes after successful AF ablation. However at this point, Callans said, "there is enough evidence to support a patient-specific decision making process when evaluating whether anticoagulants following ablation for patients with nonparoxysmal AF is a necessary treatment plan."
Additional Penn authors on this study include Michael T. Mullen, Daniele Muser, Rajeev K. Pathak, Tatsuya Hayashi, Andres Enriquez, Erica S. Zado, Pasquale Santangeli, Jeffrey S. Arkles, Robert D. Schaller, Gregory E. Supple, David S. Frankel, Fermin C. Garcia, Rajat Deo, David Lin, Michael P. Riley, Saman Nazarian, Sanjay Dixit, and Francis E. Marchlinski.

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $5.3 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 18 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $373 million awarded in the 2015 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2015, Penn Medicine provided $253.3 million to benefit our community.

University of Pennsylvania School of Medicine

Related Stroke Articles:

Retraining the brain to see after stroke
A new study out today in Neurology, provides the first evidence that rigorous visual training restores rudimentary sight in patients who went partially blind after suffering a stroke, while patients who did not train continued to get progressively worse.
Catheter ablations reduce risks of stroke in heart patients with stroke history, study finds
Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation to treat the abnormal heart rhythm lower their long-term risk of a recurrent stroke by 50 percent, according to new research from the Intermountain Medical Center Heart Institute.
Imaging stroke risk in 4-D
A new MRI technique developed at Northwestern University detects blood flow velocity to identify who is most at risk for stroke, so they can be treated accordingly.
Biomarkers may help better predict who will have a stroke
People with high levels of four biomarkers in the blood may be more likely to develop a stroke than people with low levels of the biomarkers, according to a study published in the Aug.
Pre-stroke risk factors influence long-term future stroke, dementia risk
If you had heart disease risk factors, such as high blood pressure, before your first stoke, your risk of suffering subsequent strokes and dementia long after your initial stroke may be higher.
Intervention methods of stroke need to focus on prevention for blacks to reduce stroke mortality
Blacks are four times more likely than their white counterparts to die from stroke at age 45.
Study shows area undamaged by stroke remains so, regardless of time stroke is left untreated
A study led by Achala Vagal, M.D., associate professor at the University of Cincinnati College of Medicine and a UC Health radiologist, looked at a group of untreated acute stroke patients and found that there was no evidence of time dependence on damage outcomes for the penumbra, or tissue that is at risk of progressing to dead tissue but is still salvageable if blood flow is returned in a stroke, but rather an association with collateral flow -- or rerouting of blood through clear vessels.
Immediate aspirin after mini-stroke substantially reduces risk of major stroke
Using aspirin urgently could substantially reduce the risk of major strokes in patients who have minor 'warning' events.
SAGE launches the European Stroke Journal with the European Stroke Organisation
SAGE, a world leading independent and academic publisher, is delighted to announce the launch of the European Stroke Journal, the flagship journal of the European Stroke Organisation.
The S-stroke or I-stroke?
The year 2016 is an Olympic year. Developments in high-performance swimwear for swimming continue to advance, along with other areas of scientific research.

Related Stroke Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".